Australian Clinical Labs Ltd’s (ACL) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Australian Clinical Labs Ltd is a Sell.

Australian Clinical Labs Ltd’s (ACL) 20-Day exponential moving average is 2.70, while Australian Clinical Labs Ltd’s (ACL) share price is AU$2.67, making it a Buy.

Australian Clinical Labs Ltd’s (ACL) 50-Day exponential moving average is 2.69, while Australian Clinical Labs Ltd’s (ACL) share price is AU$2.67, making it a Buy.

Australian Clinical Labs Ltd (ACL) Pivot Points

Feb 06, 2026, 09:25 AM

Classic

2.48

2.58

2.63

2.73

2.78

2.88

2.93

Fibonacci

2.58

2.64

2.67

2.73

2.79

2.82

2.88

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Australian Clinical Labs Ltd (ACL) Moving Averages

Feb 06, 2026, 09:25 AM

MA5

2.74Sell

2.72Buy

MA10

2.71Buy

MA20

2.67Buy

2.70Buy

MA50

2.73Sell

2.69Buy

MA100

2.65Buy

2.69Buy

MA200

2.69Buy

2.76Sell

Australian Clinical Labs Ltd’s (ACL) 10-Day exponential moving average is 2.71, while Australian Clinical Labs Ltd’s (ACL) share price is AU$2.67, making it a Buy.

Australian Clinical Labs Ltd’s (ACL) 100-Day exponential moving average is 2.69, while Australian Clinical Labs Ltd’s (ACL) share price is AU$2.67, making it a Buy.

Australian Clinical Labs Ltd’s (ACL) stock price is AU$2.67 and Australian Clinical Labs Ltd’s (ACL) 50-day simple moving average is 2.73, creating a Sell signal.

Australian Clinical Labs Ltd’s (ACL) stock price is AU$2.67 and Australian Clinical Labs Ltd’s (ACL) 100-day simple moving average is 2.65, creating a Buy signal.

Australian Clinical Labs Ltd’s (ACL) stock price is AU$2.67 and Australian Clinical Labs Ltd’s (ACL) 200-day simple moving average is 2.69, creating a Buy signal.

Australian Clinical Labs Ltd (ACL) Technical Indicators

Feb 06, 2026, 09:25 AM

RSI (14)

53.12

Neutral

STOCH (9,6)

53.64

Neutral

STOCHRSI (14)

61.19

Neutral

MACD (12,26)

<0.01

Sell

ADX (14)

23.45

Neutral

Williams %R

-38.81

Buy

CCI (14)

72.67

Neutral

ATR (14)

0.09

Ultimate Oscillator

46.51

Neutral

ROC

2.25

Buy

Australian Clinical Labs Ltd’s (ACL) Relative Strength Index (RSI) is 53.12, creating a Neutral signal.

Australian Clinical Labs Ltd’s (ACL) Trend Strength Indicator (ADX) is 23.45, creating a Neutral signal.

Australian Clinical Labs Ltd’s (ACL) Commodity Channel Index (CCI) is 72.67, creating a Neutral signal.

Australian Clinical Labs Ltd’s (ACL) Price Rate of Change (ROC) is 2.25, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is ACL a Buy, Hold, or Sell?

Based on ACL’s technical indicators, ACL is a Buy.

What is ACL’s RSI (14)?

ACL’s RSI (14) is 53.12, which suggests ACL is a Neutral.

What is ACL’s MACD?

ACL’s MACD is <0.01, which suggests ACL is a Sell.

What is ACL’s 5-day moving average?

ACL’s 5-day moving average is 2.74, which suggests ACL is a Sell.

What is ACL’s 20-day moving average?

ACL 20-day moving average is 2.67, which suggests ACL is a Buy.

What is ACL’s 50-day moving average?

ACL’s 50-day moving average is 2.73, which suggests ACL is a Sell.

What is ACL’s 200-day moving average?

ACL’s 200-day moving average is 2.69, which suggests ACL is a Buy.

What is ACL’s Williams % R (14)?

ACL’s Williams % R (14) is -38.81, which suggests ACL is a Buy.

What is ACL’s CCI (14)?

ACL’s CCI (14) is 72.67, which suggests ACL is a Neutral.

What is the share price of Australian Clinical Labs Ltd?

Australian Clinical Labs Ltd's share price is N/AAU$.